Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
12.93
+0.51 (4.11%)
Aug 14, 2025, 2:02 PM - Market open
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $651.17 million as of August 14, 2025. Its market cap has increased by 30.63% in one year.
Market Cap
651.17M
Enterprise Value
341.13M
1-Year Change
30.63%
Ranking
Category
Stock Price
$12.93
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $651.17M, a decrease of -12.09%. That is a compound annual growth rate of -1.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 596.00M | 28.81% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.57B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.86B |
| UnitedHealth Group | 236.89B |
| Novartis AG | 230.64B |
| AstraZeneca | 229.47B |
| Abbott Laboratories | 228.10B |
| Novo Nordisk | 223.00B |